MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202641050244 A) filed by Dr. Latha Kiran Krishna Rajendran, Bangalore, Karnataka, on April 20, for 'ai-guided design of epr-responsive nanocarriers for personalized tumor-targeted chemotherapy.'
Inventor(s) include Dr. Latha Kiran Krishna Rajendran.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "Cancer chemotherapy continues to face profound clinical limitations arising from the systemic toxicity of conventional drug delivery paradigms, wherein therapeutic agents are distributed non-selectively throughout the body, exposing healthy tissues to cytot...